- Home
- ADCT vs SMHI Comparison
ADCT vs SMHI Comparison
Compare ADCT & SMHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- SMHI
- Stock Information
- Founded
- ADCT 2011
- SMHI 1989
- Country
- ADCT Switzerland
- SMHI United States
- Employees
- ADCT N/A
- SMHI N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- SMHI Marine Transportation
- Sector
- ADCT Health Care
- SMHI Consumer Discretionary
- Exchange
- ADCT Nasdaq
- SMHI Nasdaq
- Market Cap
- ADCT 127.9M
- SMHI 142.2M
- IPO Year
- ADCT 2020
- SMHI N/A
- Fundamental
- Price
- ADCT $1.28
- SMHI $4.97
- Analyst Decision
- ADCT Strong Buy
- SMHI
- Analyst Count
- ADCT 5
- SMHI 0
- Target Price
- ADCT $7.75
- SMHI N/A
- AVG Volume (30 Days)
- ADCT 235.3K
- SMHI 123.0K
- Earning Date
- ADCT 05-14-2025
- SMHI 04-30-2025
- Dividend Yield
- ADCT N/A
- SMHI N/A
- EPS Growth
- ADCT N/A
- SMHI N/A
- EPS
- ADCT N/A
- SMHI N/A
- Revenue
- ADCT $70,837,000.00
- SMHI $264,089,999.00
- Revenue This Year
- ADCT $6.82
- SMHI $8.07
- Revenue Next Year
- ADCT $18.56
- SMHI $7.29
- P/E Ratio
- ADCT N/A
- SMHI N/A
- Revenue Growth
- ADCT 1.84
- SMHI N/A
- 52 Week Low
- ADCT $1.05
- SMHI $3.63
- 52 Week High
- ADCT $4.83
- SMHI $15.36
- Technical
- Relative Strength Index (RSI)
- ADCT 43.00
- SMHI 52.97
- Support Level
- ADCT $1.23
- SMHI $4.32
- Resistance Level
- ADCT $1.49
- SMHI $4.99
- Average True Range (ATR)
- ADCT 0.08
- SMHI 0.37
- MACD
- ADCT 0.00
- SMHI 0.04
- Stochastic Oscillator
- ADCT 25.00
- SMHI 61.50
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.